, Volume 16, Issue 7, pp 1725-1726
Date: 24 Apr 2009

AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: Rationale and Overview of the Conference

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access
This is an excerpt from the content

On January 24, 2008, the American Hepato-Pancreato-Biliary Association convened a Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer. The conference was cosponsored by the Society of Surgical Oncology, the Society for Surgery of the Alimentary Tract, The University of Texas M. D. Anderson Cancer Center, and the Gastrointestinal Symposium Steering Committee. The goals of this conference were to define resectable and borderline resectable pancreatic cancer and to review the indications and contraindications for surgery, neoadjuvant therapy, and adjuvant therapy for these lesions. The meeting took place over 1 day and was divided into three sessions addressing (1) pretreatment assessment, (2) surgical treatment, and (3) combined-modality treatment.

This issue of Annals of Surgical Oncology has three articles outlining the consensus statements, each accompanied by an editorial. The methods used in this consensus conference have been described previously.1 After c